LOGICBIO THERAPEUTICS, INC.
99 Erie Street
Cambridge, MA 02139
November 21, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F. Street, N.E.
Washington, D.C. 20549
Attention: | Paul Fischer | |
Re: | LogicBio Therapeutics, Inc. | |
Registration Statement on FormS-3 (FileNo. 333-234735) | ||
Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, LogicBio Therapeutics, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Company’s Registration Statement on FormS-3 (FileNo. 333-234735) (the “Registration Statement”), so that it will be declared effective at 4:00 p.m. Eastern Time on November 25, 2019, or as soon as possible thereafter. The Company hereby authorizes Marc Rubenstein, counsel to the Company, to orally modify or withdraw this request for acceleration.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would inform Marc Rubenstein of Ropes & Gray LLP, counsel to the Company, at (617)951-7826.
Very truly yours, | ||
LOGICBIO THERAPEUTICS, INC. | ||
By: | /s/ Matthias Jaffé | |
Matthias Jaffé | ||
Chief Financial Officer |